PURPOSE: To evaluate the clinical outcomes of cataract surgery using novel diffractive trifocal intraocular lenses (IOLs) in Koreans. MATERIALS AND METHODS: This was a retrospective, consecutive, interventional study of cataract surgery using POD FineVision IOL implantation. Complete ophthalmologic examinations were performed preoperatively and postoperatively. Defocus curves were assessed over a range of +1.5 to -4.0 diopters (D) in 0.5-D steps at one month postoperatively. Uncorrected distant (UDVA), intermediate (UIVA) and near (UNVA) visual acuities and corrected distant (CDVA), and distant-corrected intermediate (DCIVA) and distant-corrected near (DCNVA) visual acuities were assessed one month postoperatively, and manifest refraction was performed during every visit. RESULT: The study analyzed 31 eyes in 20 patients. There were statistically significant improvements in UDVA, UIVA, UNVA, CDVA, DCIVA, and DCNVA (P < 0.001). The final postoperative refractive outcomes showed statistically significant myopic shifts compared to the target refraction based on SRK/T, SRK-II, Haigis, and Hoffer Q formulas (P < 0.001). CONCLUSION: POD FineVision IOLs provide stable visual restoration with improvements of near and intermediate vision in presbyopic eyes. POD FineVision IOLs show myopic shift in a Korean population; therefore, surgeons should be cautious when selecting IOL power in such patients.